![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgESTPDC5uOa2K4IluykkIbFt8c0hM5aq5e07D949E7Hssyp3NB2HIGhnCmnE13RFazsp4HIAPw5_s_OdD-nBs2AzHcz72FCDv89vgvS7Z5mH_PVe-tuGhWlSo_KX9B-VbEXjFXlwExivw/s320/medicine-jumble%5B1%5D.jpg)
The discovery dates back to 1958, which contributed to the characterization of T. Omura and R. Sato. [5] The human cytochrome P450 attract the attention of scientists precisely because it is significantly involved in the metabolism of xenobiotics. At the end of 2006 was crystallized seven mammalian forms of these enzymes (5 of them human) and published in seventeen structures (11 of them human). [6]
Detailed analysis of cytochrome P450 can help determine whether the drugs act as a substrate, inducer or inhibitor. This knowledge will support the regulation of drug administration and the anticipation of adverse events (clinically significant drug interactions that may lead to drug toxicity, reduce or increase the contrast of pharmacological effects).
Detailed analysis of cytochrome P450 can help determine whether the drugs act as a substrate, inducer or inhibitor. This knowledge will support the regulation of drug administration and the anticipation of adverse events (clinically significant drug interactions that may lead to drug toxicity, reduce or increase the contrast of pharmacological effects).
The completion of these projects, it is necessary to assess the structural properties of the access routes to the active site and then find the common features and differences between different forms of cytochrome particularly in terms of their length, preferences, presence and orientation of residues. This appreciation is to my work, which together with the study of enzyme flexibility should help to understanding the mechanism of function of cytochrome P450 primarily in xenobiotic metabolism. Flexibility as the second essential factor is not the subject of this research.
No comments:
Post a Comment